© 2020 MJH Life Sciences and OncLive. All rights reserved.
September 11, 2013
Alex A. Adjei, MD, PhD, Professor and Chair, Department of Medicine, Katherine Anne Gioia Chair in Cancer Medicine, Senior Vice President, Clinical Research, Roswell Park Cancer Institute, discusses eye toxicity from MEK inhibitors.
June 12, 2012
Dr. Alex Adjei, from Roswell Park Cancer Institute, on the Need for Targeted Therapy Education